4-hydroxy-3-[2-oxo-3-(thieno[3,2-b]pyridine-2-sulfonylamino)-pyrrolidin-1-ylmethyl]-benzamidine (PR1) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.09
Number of clusters 37
Number of clusters representing 95% 9
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.7143
ΔGstrain (kcal/mol) 0.7302
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 1898 0 2.8904
2 1852 0.0145 2.4947
3 1817 0.0258 2.962
4 1738 0.0521 2.0959
5 1091 0.3278 2.0915
6 553 0.7302 1.8548
7 359 0.9861 2.5469
8 342 1.0148 2.0276
9 187 1.3723 2.1821
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)